Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2008-6-27
pubmed:abstractText
We hypothesize that combining angiopoietin-1 (ANG-1) or ANG-2 with vascular endothelial growth factor (VEGF) improves myocardial perfusion and contractile function by modulating vascular adaptation of neoangiogenic microvessels in a chronic ischemic swine model. Four weeks after occlusion of the left circumflex coronary artery (LCx), animals were injected with AdVEGF(165) (n=6), AdVEGF(165)+AdANG-1 (n=6), AdVEGF(165)+AdANG-2 (n=6) or control vector (n=5) into the left ventricular posterolateral wall. Regional perfusion by fluorescent microspheres and segmental myocardial tissue velocity by tissue Doppler imaging (TDI) were assessed at baseline, 4 weeks post occlusion and 4 weeks post therapy. Despite similar vascular growth following VEGF+ANG-1 and VEGF+ANG-2 treatments, transmural myocardial contractility improved only when VEGF was paired with ANG-1. In contrast, regional systolic function deteriorated uniformly across subepicardial, mid-myocardial and subendocardial segments in VEGF and VEGF+ANG-2 treated groups. Contractile improvement was associated with enhanced vascular stability through augmented arteriole formation, tight structural integration between VE-cadherin and beta-catenin at endothelial junctions and improved cross-talk between endothelium and myocardium. Structural stability of developing intramyocardial microvessels contributes to systolic function during ischemic neovascularization. Coordinated regulation of angiogenic revascularization that supports vascular stability is a key aspect in improving therapeutic outcomes in ischemic myocardium.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1095-8584
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
45
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
70-80
pubmed:meshHeading
pubmed-meshheading:18514708-Adenoviridae, pubmed-meshheading:18514708-Angiopoietin-1, pubmed-meshheading:18514708-Angiopoietin-2, pubmed-meshheading:18514708-Animals, pubmed-meshheading:18514708-Antigens, CD, pubmed-meshheading:18514708-Arterioles, pubmed-meshheading:18514708-Cadherins, pubmed-meshheading:18514708-Chronic Disease, pubmed-meshheading:18514708-Coronary Circulation, pubmed-meshheading:18514708-Coronary Vessels, pubmed-meshheading:18514708-Disease Models, Animal, pubmed-meshheading:18514708-Echocardiography, Doppler, pubmed-meshheading:18514708-Endothelium, pubmed-meshheading:18514708-Female, pubmed-meshheading:18514708-Gene Therapy, pubmed-meshheading:18514708-Male, pubmed-meshheading:18514708-Myocardial Contraction, pubmed-meshheading:18514708-Myocardial Ischemia, pubmed-meshheading:18514708-Myocardium, pubmed-meshheading:18514708-Neovascularization, Physiologic, pubmed-meshheading:18514708-Recovery of Function, pubmed-meshheading:18514708-Swine, pubmed-meshheading:18514708-Time Factors, pubmed-meshheading:18514708-Vascular Endothelial Growth Factor A, pubmed-meshheading:18514708-beta Catenin
pubmed:year
2008
pubmed:articleTitle
Structural stability of neoangiogenic intramyocardial microvessels supports functional recovery in chronic ischemic myocardium.
pubmed:affiliation
Research and Development Unit, National Heart Center, Singapore. Winston_SHIM_SN@nhc.com.sg
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't